Schering-Plough Aquaculture Profile
Schering-Plough Animal Health Corporation, Worldwide Aquaculture, is a world leader in the development of vaccines and antibiotics for the treatment and control of diseases in farmed fish and other aquatic species in the global aquaculture industry.
Headquartered in Kenilworth, N.J., Schering-Plough Corporation is a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide.
Schering-Plough Aquaculture offers fully-integrated disease management solutions for the treatment and control of diseases in farmed fish and other aquatic species. Its commitment to providing cost-effective, environmentally friendly aquaculture solutions throughout the production cycle is exemplified through innovative research and development, quality products, technical services and global industry support.
Schering-Plough Aquaculture offers a diverse selection of effective aquaculture pharmaceuticals such as SLICE* and Aquaflor* to control and manage important aquatic pathogens. In addition, a unique Total Protection Strategy approach to maintaining fish health is also offered through a wide range of patented AquaVac* monovalent and combination vaccines for the prevention of many fish diseases infecting cultured species. Schering-Plough Aquaculture exclusively offers vaccines for oral administration to fish as well as injection and immersion.
The Total Protection Strategies approach to disease prevention, provides on farm flexibility and optimum protection, while minimizing stress, handling of fish and overall disruption within the fish farming operation. Schering-Plough Aquaculture technical experts are also available to build customized vaccination and treatment programs to meet your specific needs.
We believe that through
your success
comes
our success.
|
|
|
(Click on the Product titles for more information)
Active immunization against
Enteric Redmouth disease to reduce mortality caused
by the Hagerman Type I strain and EX5 biotype of
Yersinia ruckeri.
Aquaflor is a florfenicol based broad spectrum antibiotic active against Gram-positive and Gram-negative bacteria isolated from domestic animals. 50% medicated premix.
Aquaflor is a florfenicol based broad spectrum antibiotic active against Gram-positive and Gram-negative bacteria isolated from domestic animals. 2% premix solution.
For the treatment of pseudotuberculosis in Perciformes (yellowtail, amberjack, sea bream, tilapia, sea bass, horse mackerel).
For the treatment of streptococcosis caused by Lactococcus garvieae in Perciformes.
For the reduction of mortality in fish caused by sulfisozole-sensitive strains of bacteria.
For the treatment of infections caused by organisms susceptible to trimethoprim/sulfadiazine
For the treatment and prevention of lice infestations in salmonids
For use in healthy rainbow trout to prevent Enteric Redmouth Disease caused by Yersinia ruckeri.
For use in healthy rainbow trout 26 g and larger primed by immersion in AquaVac* ERM to prevent Enteric Redmouth Disease caused by Yersinia ruckeri.
for the reduction in mortality due to furunculosis disease caused by Aeromonas salmonicida in healthy salmonids.
For the prevention of furunculosis caused by Aeromonas salmonicida in healthy Atlantic salmonids of 20g and larger.
For the prevention of furunculosis, caused by Aeromonas salmonicida in healthy fish of 5g and larger.
For the reduction in mortality due to furunculosis and vibriosis disease caused by Aeromonas salmonicida and Vibrio anguillarum (biotype I and II ) in healthy salmonids.
for use in healthy fish of 3g and larger to prevent vibriosis caused by two strains of Vibrio anguillarum.
For use in healthy fish of 3g and larger to prevent vibriosis caused by two strains of Vibrio anguillarum.
A completely natural feed ingredient which aids the non-specific immune response to a range of pathogens.
|
|
